Swiftsure International Inc.
Holmes Biopharma – TVA Productions to Launch National and International MediaBlitz

Holmes Biopharma Inc. / Miscellaneous

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.
----------------------------------------------------------------------

Holmes Biopharma – TVA Productions to Launch National and International
MediaBlitz

Scottsdale, Arizona – August 15, 2007 – Holmes Biopharma, Inc. (Symbol
HHJA, security code A0KDRX) is pleased to announce TVA Productions has been
retained to develop and launch a national media campaign that will focus on
building brand awareness for Holmes and its clinical research subsidiary
Qualia Clinical Service Inc. ('Qualia').
Under this program, TVA will assist Holmes in expanding its awareness
within the business community and to the general public both nationally and
internationally. TVA will also focus on building name brand awareness for
services offered by Qualia.
TVA's 'MediaBlitz!®' campaign for Holmes is designed to build brand
awareness with the public and business community by mass dissemination of
information on TV, print, radio and the Internet. The campaign includes
production and nationwide distribution of a TV News Spotlight (2-8 min.);
Newsbreak; In-Flight Video; Internet Streaming Video; 10-minute Corporate
Video, DVD, Trade Show Loop Presentation; a sixty second Radio News
Release, professionally recorded and distributed to over 6,000 Radio
stations; and 1-3 column News Features with photo and contact info
distributed to 10,000 newspapers reaching an estimated 20 million readers.
The TV programs will air for at least six months on national and local
cable, satellite and broadcast affiliates throughout the U.S. and Europe.
Programs will air in primarily Top 50 markets between 6:30 a.m. and 10:30
p.m. daily -- with the majority expected to be during prime-time hours
(5:30 p.m. - 10:30 p.m.). Over 90 million households will have access to
the programming. The TV Spotlight will air daily on one or more major
Airlines for at least one month as in-flight programming, 25,000 TV
newsbreak airings. A minimum of 100 Newspaper Feature placements and 200
Radio News Release placements are also guaranteed as part of the
MediaBlitz!® package.
ABOUT TVA PRODUCTIONS
TVA Productions, located in Studio City, California
(http://www.tvaproductions.com/), is one of the leading media production
and news placement syndicates in North America -- providing HD production &
broadcast facilities, extensive distribution & tracking resources, and a
worldwide team. Since 1987, TVA has provided performance-based media
booking services have been successfully used by Fortune 500 companies,
emerging companies, ad agencies, PR firms, national associations,
non-profits, and government agencies worldwide. TVA's team has won over 40
Golden Mike, Addy, Emmy, Clio, Telly and Aegis awards. Clients include
Baxter Medical, Cable & Wireless, Canon, Cessna, Epson, FEMA, Kellogg's,
Hill & Knowlton, LDS Church, Lexus, Marriott, Nickelodeon, Occidental
Petroleum, Ogilvy, Pepsi, Princess Cruises, Qualcomm, Salvation Army, Sony,
Space Adventures, Technicolor, Teradata,

About Holmes:
Holmes Biopharma Inc. is a contract research organization focused on
providing integrated and cost effective clinical development services that
help the pharmaceutical industry introduce new drug products rapidly from
laboratory to the market. For more information about the company please
visit our website at www.holmesbiopharma.com.

On behalf of the Board of Directors 

John F. Metcalfe, President

Certain statements in this press release constitute 'forward looking
statements' within the meaning of the United States Securities Legislation.
The Company's actual results could differ from those in the forward-looking
statements. Do not construe this information as investment advice. This is
not a solicitation to buy or sell securities. This does not purport to be a
complete analysis of the Company. Investing in securities is speculative
and carries a high degree of risk. Past performance does not guarantee
future results. Readers should consult their own independent advisers with
any investment, including any contemplated investment. All information
contained in this press release should be independently investigated. This
press release contains forward-looking statements. These remarks involve
risks and uncertainties.  Risks are not limited to quarterly fluctuations
in results or the companies’ management of growth and competition. Other
risks are detailed in the Company's SEC filings.  Actual results may differ
materially from such information set forth herein.

Contact:
Investor Relations
Holmes Biopharma Inc. 
8655 East Via De Ventura, G-200, Scottsdale AZ 85258
Tel: 001-866-694-2803 
www.holmesbiopharma.com
DGAP 15.08.2007 
----------------------------------------------------------------------